Aviva PLC Repligen Corp Transaction History

Aviva PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$120.0 - $182.95 $1.94 Million - $2.95 Million	-16,130 Reduced 33.32%	32,275 $4.07 Million
Q1 2024 May 14, 2024	BUY	$170.78 - $208.42 $3.99 Million - $4.87 Million	23,362 Added 93.29%	48,405 $8.9 Million
Q4 2023 Feb 09, 2024	BUY	$114.17 - $185.35 $2.86 Million - $4.64 Million	25,043 New	25,043 $4.5 Million
Q2 2023 Aug 10, 2023	BUY	$138.42 - $180.31 $774,459 - $1.01 Million	5,595 New	5,595 $791,000
Q2 2021 Aug 10, 2021	SELL	$165.87 - $220.95 $1.05 Million - $1.39 Million	-6,307 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$180.37 - $226.26 $440,102 - $552,074	-2,440 Reduced 27.9%	6,307 $1.23 Million
Q4 2020 Feb 10, 2021	SELL	$148.08 - $206.57 $1.05 Million - $1.47 Million	-7,093 Reduced 44.78%	8,747 $1.68 Million
Q3 2020 Nov 12, 2020	SELL	$122.51 - $158.27 $408,815 - $528,146	-3,337 Reduced 17.4%	15,840 $2.34 Million
Q2 2020 Aug 13, 2020	SELL	$94.33 - $140.48 $1.8 Million - $2.68 Million	-19,049 Reduced 49.83%	19,177 $2.37 Million
Q1 2020 May 14, 2020	BUY	$84.96 - $109.14 $1.36 Million - $1.75 Million	16,045 Added 72.34%	38,226 $3.69 Million
Q4 2019 Feb 10, 2020	BUY	$73.84 - $93.08 $1.64 Million - $2.06 Million	22,181 New	22,181 $2.05 Million

485

54.1M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.21B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.